Caprock Group, Inc. Pfizer Inc Transaction History

Caprock Group, Inc.

$3.21 Billion
Q1 2025

A detailed history of Caprock Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Caprock Group, Inc. holds 135,003 shares of PFE stock, worth $3.15 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

135,003

Previous 109,194 23.64%

Holding current value

$3.15 Million

Previous $2.9 Million 18.09%

% of portfolio

0.11%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $645,483 - $700,198	25,809 Added 23.64%	135,003 $3.42 Million
Q4 2024 Jan 23, 2025	SELL	$24.8 - $30.19 $1.51 Million - $1.83 Million	-60,781 Reduced 35.76%	109,194 $2.9 Million
Q3 2024 Nov 07, 2024	SELL	$27.7 - $31.39 $38,336 - $43,443	-1,384 Reduced 0.81%	169,975 $4.92 Million
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $1.84 Million - $2.16 Million	72,818 Added 73.9%	171,359 $4.79 Million
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $75,262 - $86,425	2,907 Added 3.04%	98,541 $2.73 Million
Q4 2023 Jan 18, 2024	BUY	$26.13 - $33.94 $916,196 - $1.19 Million	35,063 Added 57.89%	95,634 $2.75 Million
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $99,286 - $116,055	-3,094 Reduced 4.86%	60,571 $2.01 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $63,535 - $73,508	1,759 Added 2.84%	63,665 $2.34 Million
Q1 2023 Apr 26, 2023	BUY	$39.39 - $51.28 $885,762 - $1.15 Million	22,487 Added 57.05%	61,906 $2.53 Million
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $195,431 - $255,114	4,681 Added 13.48%	39,419 $0
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $184,886 - $225,699	4,225 Added 13.85%	34,738 $1.52 Million
Q2 2022 Jul 26, 2022	BUY	$46.53 - $55.17 $391,736 - $464,476	8,419 Added 38.11%	30,513 $1.6 Million
Q1 2022 Apr 12, 2022	BUY	$45.75 - $56.69 $46,482 - $57,597	1,016 Added 4.82%	22,094 $1.14 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $1.66 Million - $2.47 Million	-40,264 Reduced 65.64%	21,078 $1.25 Million
Q3 2021 Oct 07, 2021	SELL	$39.25 - $50.42 $12,128 - $15,579	-309 Reduced 0.5%	61,342 $2.64 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $22,084 - $25,018	-615 Reduced 0.99%	61,651 $2.41 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $19,424 - $21,906	-580 Reduced 0.92%	62,266 $2.26 Million
Q4 2020 Jan 29, 2021	SELL	$33.47 - $42.56 $56,062 - $71,288	-1,675 Reduced 2.6%	62,846 $2.31 Million
Q3 2020 Oct 29, 2020	SELL	$31.75 - $37.25 $495,808 - $581,696	-15,616 Reduced 19.49%	64,521 $2.37 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $240,116 - $291,296	7,972 Added 11.05%	80,137 $2.62 Million
Q1 2020 Apr 28, 2020	BUY	$27.03 - $38.62 $1.53 Million - $2.18 Million	56,443 Added 359.01%	72,165 $2.36 Million
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $34,697 - $39,377	1,054 Added 7.19%	15,722 $616,000
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $131,584 - $170,626	-4,050 Reduced 21.64%	14,668 $527,000
Q2 2019 Jul 23, 2019	SELL	$36.98 - $41.52 $1.85 Million - $2.08 Million	-49,985 Reduced 72.76%	18,718 $811,000
Q1 2019 Apr 12, 2019	SELL	$37.5 - $41.2 $39,187 - $43,054	-1,045 Reduced 1.5%	68,703 $2.92 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $61,167 - $69,737	-1,590 Reduced 2.23%	69,748 $3.05 Million
Q3 2018 Oct 17, 2018	SELL	$34.47 - $41.81 $128,262 - $155,575	-3,721 Reduced 4.96%	71,338 $3.14 Million
Q2 2018 Jul 23, 2018	SELL	$32.98 - $35.16 $338,572 - $360,952	-10,266 Reduced 12.03%	75,059 $2.72 Million
Q1 2018 Apr 23, 2018	SELL	$31.91 - $37.02 $79,551 - $92,290	-2,493 Reduced 2.84%	85,325 $3.03 Million
Q4 2017 Jan 17, 2018	SELL	$33.26 - $35.29 $413,521 - $438,760	-12,433 Reduced 12.4%	87,818 $3.21 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $3.11 Million - $3.42 Million	100,251	100,251 $3.58 Million

Others Institutions Holding PFE

# of Institutions

3,369

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $131B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Pfizer Inc Transaction History